Alkermes

CNBC interviews Alkermes CEO about antidepressant comeback
Thu, 10/27/16 - 04:08 pm
Why Despite Alkermes Success, Suicidal Ideation Still Eludes Big Pharma
24/7 Wall St
Sat, 10/22/16 - 03:30 pm
Alkermes
depression
suicide
suicidal ideation
ALKS 5461
A Biotech's Depression Drug Returns From Dead, Setting Up Test For FDA
Forbes
Thu, 10/20/16 - 08:13 pm
biotech
FDA
Alkermes
clinical depression
ALKS 5461
antidepressants
GSK, Merck shares win as 2016 brings big moves. Losers? You know who
Fierce Pharma
Tue, 08/23/16 - 10:00 am
GSK
Merck
Valeant Pharmaceuticals
Endo International
Sagent Pharmaceuticals
Alkermes
Shire
Perrigo
FDA Prevails in Otsuka Challenge to Scope of ABILIFY 3-Year Exclusivity, Leaving Intact ARISTADA 505(b)(2) NDA Approval
FDA Law Blog
Mon, 08/1/16 - 09:36 am
FDA
Otsuka
Abilify
exclusivity
Aristada
Alkermes
Alkermes CEO, Richard Pops, On ALKS 5461 And Challenges In Developing New Drugs For Depression
Forbes
Tue, 02/9/16 - 09:28 am
Alkermes
Richard Pops
ALKS 5461
clinical depression
Alkermes slammed as top depression drug fails two PhIIIs
Fierce Biotech
Thu, 01/21/16 - 05:42 pm
Alkermes
ALKS-5461
clinical depression
clinical trials
Alkermes’s Aristada Demonstrates High Efficacy as Schizophrenia Therapy
Yahoo/Market Realist
Mon, 10/12/15 - 04:31 pm
Alkermes
Aristada
schizophrenia
Alkermes wins an FDA nod for its monthly schizophrenia drug
Fierce Biotech
Tue, 10/6/15 - 09:58 am
FDA
Alkermes
schizophrenia
Aristada
Abilify
5 Big FDA Decisions Expected in August
24/7 Wall St
Thu, 08/6/15 - 02:58 pm
FDA
Exelixis
vemurafenib
aripiprazole lauroxil
Alkermes
evolocumab
Amgen
Bristol-Myers Squibb
Opdivo
Clovis Oncology
rociletinib
Alkermes heads to Phase III with a schizophrenia drug designed to spare the waistline
Fierce Biotech
Mon, 04/6/15 - 11:45 am
Alkermes
schizophrenia
ALKS 3831
Alkermes shares down after it stops development of pain pill
Bizjournals.com
Tue, 02/24/15 - 02:16 pm
Alkermes
painkillers
ALKS 7106
Alkermes says its more tolerable Tecfidera rival is ready for pivotal challenge
Fierce Biotech
Mon, 02/9/15 - 05:59 pm
Alkermes
ALKS 8700
MS
multiple sclerosis
Biogen Idec
Tecfidera
Alkermes sees PhII promise for schizophrenia drug that doesn't pack on pounds
Fierce Biotech
Wed, 01/7/15 - 09:21 am
Alkermes
schizophrenia
ALKS 3831
Alkermes Incurs Wider Q3 Loss but Revenues Grow Y/Y
Yahoo/Zacks
Sat, 11/1/14 - 12:46 pm
Alkermes
earnings
3 Likely Biotech Buyout Candidates
24/7 Wall St
Mon, 09/29/14 - 09:27 am
biotech
M&A
Alkermes
Jazz Pharmaceuticals
Salix
Alkermes Completes Enrolment for Phase II ALKS 3831 Study
Yahoo/Zacks.com
Fri, 09/5/14 - 07:57 am
Alkermes
ALKS 3831
schizophrenia
Alkermes closer to launching once-monthly schizophrenia drug into a crowded market
Fierce Biotech
Tue, 08/26/14 - 10:36 pm
Alkermes
Abilify Maintena
schizophrenia
Alkermes' Pipeline Development Impresses, Key Updates Ahead
Yahoo/Reuters
Tue, 07/22/14 - 08:54 am
Alkermes
Invega Sustenna
ALKS 3831
aripiprazole lauroxil
ALKS 5461
Alkermes takes its Tecfidera beater into clinical trials for MS
Fierce Biotech
Thu, 07/17/14 - 10:01 am
Alkermes
Tecfidera
MS
multiple sclerosis

Pages